Sg Americas Securities, LLC Iovance Biotherapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$7.78 - $14.19 $3.46 Million - $6.32 Million	445,172 Added 836.51%	498,390 $4 Million
Q1 2024 May 06, 2024	SELL	$7.59 - $17.47 $269,528 - $620,377	-35,511 Reduced 40.02%	53,218 $789,000
Q4 2023 Jan 12, 2024	SELL	$3.3 - $8.89 $619,291 - $1.67 Million	-187,664 Reduced 67.9%	88,729 $721,000
Q3 2023 Oct 13, 2023	SELL	$4.44 - $8.79 $404,368 - $800,540	-91,074 Reduced 24.78%	276,393 $1.26 Million
Q2 2023 Jul 10, 2023	BUY	$5.36 - $9.06 $1.97 Million - $3.33 Million	367,467 New	367,467 $2.59 Million
Q2 2022 Jul 29, 2022	SELL	$6.38 - $18.33 $953,988 - $2.74 Million	-149,528 Reduced 64.71%	81,549 $900,000
Q1 2022 Apr 29, 2022	BUY	$12.38 - $19.1 $2.79 Million - $4.31 Million	225,452 Added 4008.04%	231,077 $3.85 Million
Q4 2021 Feb 07, 2022	SELL	$16.55 - $27.63 $216,854 - $362,035	-13,103 Reduced 69.96%	5,625 $107,000
Q3 2021 Nov 01, 2021	SELL	$20.35 - $26.63 $80,240 - $105,002	-3,943 Reduced 17.39%	18,728 $462,000
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $5,192 - $10,516	-318 Reduced 1.38%	22,671 $590,000
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $443,180 - $812,936	15,458 Added 205.26%	22,989 $728,000
Q4 2020 Feb 04, 2021	SELL	$28.04 - $50.26 $802,000 - $1.44 Million	-28,602 Reduced 79.16%	7,531 $349,000
Q3 2020 Nov 09, 2020	BUY	$27.75 - $36.3 $820,290 - $1.07 Million	29,560 Added 449.72%	36,133 $1.19 Million
Q2 2020 Jul 20, 2020	SELL	$27.21 - $41.0 $561,423 - $845,953	-20,633 Reduced 75.84%	6,573 $180,000
Q1 2020 Apr 30, 2020	BUY	$19.54 - $38.85 $111,182 - $221,056	5,690 Added 26.45%	27,206 $814,000
Q4 2019 Jan 28, 2020	BUY	$17.95 - $29.41 $32,758 - $53,673	1,825 Added 9.27%	21,516 $596,000
Q3 2019 Nov 04, 2019	SELL	$17.99 - $26.0 $2.08 Million - $3 Million	-115,410 Reduced 85.42%	19,691 $358,000
Q2 2019 Jul 29, 2019	BUY	$9.78 - $24.52 $643,836 - $1.61 Million	65,832 Added 95.04%	135,101 $3.31 Million
Q1 2019 Apr 29, 2019	BUY	$8.41 - $11.26 $411,820 - $551,379	48,968 Added 241.21%	69,269 $659,000
Q4 2018 Feb 01, 2019	BUY	$7.51 - $11.93 $152,460 - $242,190	20,301 New	20,301 $180,000
Q3 2018 Nov 06, 2018	SELL	$11.25 - $17.7 $102,555 - $161,353	-9,116 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$12.45 - $16.95 $45,567 - $62,037	-3,660 Reduced 28.65%	9,116 $117,000
Q1 2018 May 03, 2018	BUY	$8.1 - $19.5 $103,485 - $249,132	12,776 New	12,776 $216,000
Q4 2017 Jan 24, 2018	SELL	$6.65 - $9.25 $334,461 - $465,228	-50,295 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$4.45 - $8.55 $223,812 - $430,022	50,295	50,295 $390,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account